MSB 2.51% 97.0¢ mesoblast limited

Cell Therapy News/Articles, page-6987

  1. 548 Posts.
    lightbulb Created with Sketch. 124
    dplane these are exactly my thoughts, makes the ARDS trial results a MASSIVE moment for MSB. Is there any way the FDA could have had a look at the interim results ( 90 patients) just gone?, or is there no communication between FDA and NIH and DSMB????????
 
watchlist Created with Sketch. Add MSB (ASX) to my watchlist
arrow-down-2 Created with Sketch. arrow-down-2 Created with Sketch.